Publications

Healthcare & Life Sciences

Alexion, AstraZeneca Rare Disease

Spending on orphan medicinal products across Europe: What drives it, and is it sustainable?

Healthcare & Life Sciences

Danish Guides and Scouts Association

Evaluating the societal impact of scouting

Healthcare & Life Sciences

EUCOPE

An EU Access Toolbox for Orphan Medicinal Products that enables early and equitable access

Healthcare & Life Sciences

GSK

Rotavirus vaccine – Technical and economic arguments regarding implementation of rotavirus vaccination in the Danish immunisation programme

Healthcare & Life Sciences

US Hereditary Angioedema Association (HAEA)

Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

Healthcare & Life Sciences

PhRMA

Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy

Healthcare & Life Sciences

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Cost and value of regulatory data protection

Healthcare & Life Sciences

EURORDIS, Alexion AstraZeneca Rare Disease, Takeda, Orphanet

Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products

Healthcare & Life Sciences

Novartis Healthcare A/S

Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark

Healthcare & Life Sciences

OD Expert Group

European Union Health Technology Assessment Fit for Rare Diseases

Healthcare & Life Sciences

Novo Nordisk A/S

European trade in pharmaceutical goods

Healthcare & Life Sciences

Alliance for Safe Online Pharmacy in the EU (ASOP EU)

Unlocking the benefits of online access to prescription medicines across the EU

Healthcare & Life Sciences

Novo Nordisk

The economic impact of the pharmaceutical industry in Europe

Healthcare & Life Sciences

PhRMA

Regulatory data protection – How adopting regulatory data protection can increase medicine availability, innovation, and investment

Healthcare & Life Sciences

Economists Without Borders / Impactly

New tool assesses the impact of initiatives against loneliness

Healthcare & Life Sciences

Takeda

Spending on orphan medicinal products across Europe: What drives it, and is it sustainable?

Evaluating the societal impact of scouting

An EU Access Toolbox for Orphan Medicinal Products that enables early and equitable access

Rotavirus vaccine – Technical and economic arguments regarding implementation of rotavirus vaccination in the Danish immunisation programme

Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy

Cost and value of regulatory data protection

Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products

Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark

European Union Health Technology Assessment Fit for Rare Diseases

European trade in pharmaceutical goods

Unlocking the benefits of online access to prescription medicines across the EU

The economic impact of the pharmaceutical industry in Europe

Regulatory data protection – How adopting regulatory data protection can increase medicine availability, innovation, and investment

New tool assesses the impact of initiatives against loneliness

Development of novel therapies